Kumar Tanishq, Singh Arihant, Thakre Swedaj, Acharya Sourya, Shukla Samarth, Kumar Sunil
Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2023 Jul 19;15(7):e42131. doi: 10.7759/cureus.42131. eCollection 2023 Jul.
Cardiovascular disorders have always been the top contributors to the number of mortality occurring worldwide. But the last few decades have seen a drop in those numbers as the lives of millions of people have been saved due to ground-breaking advances in both therapeutic and surgical treatment modalities. Achieving this level of scientific glory in cardiology was a challenging feat. The credit goes to the scientists and physicians of the previous century who, despite their time's technological limitations, made discoveries and laid a solid foundation for modern medicine. Valvular complications are a major part of the global burden of cardiac diseases. The ongoing development of heart valve replacements remains a fascinating subject, as it continues to progress. Valve replacements comprise either mechanical heart valves or bioprosthetic heart valves. Both types of valves have their merits and demerits; their usage depends mostly on individual patient requirements. This article aims to review the evolution of the implantation of heart valves, and it is the objective of this article to give credit to scientists and physicians for their contributions. The article highlights the research gaps in finding more durable materials and the scope of further research in creating a heart valve that can be universally used for better patient outcomes.
心血管疾病一直是全球死亡人数的首要原因。但在过去几十年里,这一数字有所下降,因为治疗和手术治疗方式的突破性进展挽救了数百万人的生命。在心脏病学领域取得如此高的科学成就,是一项具有挑战性的壮举。这要归功于上世纪的科学家和医生,尽管当时技术有限,但他们做出了诸多发现,为现代医学奠定了坚实基础。瓣膜并发症是全球心脏疾病负担的主要组成部分。心脏瓣膜置换技术的不断发展仍然是一个引人入胜的课题,因为它在持续进步。瓣膜置换包括机械心脏瓣膜或生物人工心脏瓣膜。这两种瓣膜都有其优缺点;其使用主要取决于个体患者的需求。本文旨在回顾心脏瓣膜植入技术的发展历程,并肯定科学家和医生的贡献。文章强调了在寻找更耐用材料方面的研究空白,以及在研发一种可普遍用于改善患者预后的心脏瓣膜方面的进一步研究范围。